Diagnosis and Management of High-Grade Soft Tissue Sarcoma

Clinical Presentation and Diagnosis

A mass size greater than 5 cm is a critical red flag that mandates specialist evaluation, as masses exceeding this threshold have significantly higher malignancy risk, according to the British Journal of Cancer and the Journal of the American College of Radiology 1, 3
Progressive growth over time with ill-defined borders on imaging represents concerning behavior inconsistent with typical benign lesions, as noted by the British Journal of Cancer 1
Possible infiltration of adjacent structures indicates aggressive local invasion, a hallmark of high-grade sarcomas, according to the British Journal of Cancer 1
Deep location in the extremities substantially increases malignancy probability compared to superficial masses, as reported by the Journal of the American College of Radiology 3, 5
Reactive lymphadenopathy suggests regional disease spread, which occurs in certain sarcoma subtypes and represents an adverse prognostic factor requiring more aggressive treatment planning, according to the Annals of Oncology 6, 7

Refer immediately to a specialized sarcoma multidisciplinary team before any biopsy attempt, as improper biopsy technique outside reference centers can contaminate tissues and compromise limb-salvage surgery, as recommended by the British Journal of Cancer and the National Institute for Health and Care Excellence (NICE) 1, 2
All patients with suspected soft tissue sarcoma must be managed by specialist teams to optimize morbidity and mortality outcomes, according to the British Journal of Cancer and NICE 1, 2

MRI of the affected area with contrast is mandatory as it provides the most accurate information for diagnosis, surgical planning, and radiotherapy planning for extremity soft tissue tumors, as recommended by the British Journal of Cancer 1
CT scans of the chest, abdomen, and pelvis must be performed to exclude metastases, as soft tissue sarcomas predominantly metastasize to the lungs, according to the British Journal of Cancer and the Annals of Oncology 1, 6
Ultrasound or cross-sectional imaging of regional lymph nodes is essential given the reactive lymphadenopathy, particularly important for certain sarcoma subtypes, as reported by the Annals of Oncology 6, 7

Wide surgical excision with negative margins is standard treatment, requiring removal of the tumor with a rim of normal tissue, as recommended by the Annals of Oncology and the European Society for Medical Oncology (ESMO) 6, 7
Adjuvant radiotherapy will likely be required given the size, high grade, and deep location, according to the Annals of Oncology and ESMO 6, 7
Adjuvant chemotherapy may be considered as an option for high-risk patients through shared decision-making, though it is not standard treatment in adult-type soft tissue sarcomas, as reported by the Annals of Oncology and ESMO 6, 7

Size greater than 5 cm, high grade, deep location, and possible lymph node involvement represent multiple adverse prognostic factors that necessitate aggressive multimodal treatment, according to the Annals of Oncology and ESMO 6, 7
Timely referral to a specialized center is the single most important factor affecting both morbidity and mortality outcomes in extremity soft tissue sarcomas, as noted by the British Journal of Cancer and NICE 1, 2